Several lines of evidence suggest that EBV-specific CD8 T cells are important for the control of EBV long term (51), including successful treatment of EBV-associated lymphoproliferative disorders and post-transplant associated EBV infections by adoptive transfer of EBV-specific CD8 T cells (52, 53). The gene discussed is CD8A; the disease is lymphoproliferative syndrome.